INS and cystic fibrosis: Contrary to earlier reports of increased protein breakdown in CF, baseline protein catabolism was comparable to that of healthy controls, and no significant differences in any indices of protein turnover—including endogenous protein breakdown—were observed between insulin‐ and placebo‐treated groups, suggesting improved metabolic status in contemporary CF populations [43].